机构:[a]Department of General Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China临床科室普外科首都医科大学附属安贞医院[b]Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China医技科室病理科首都医科大学附属安贞医院[c]School of Public Health, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
Background: Central lymph node metastasis(CLNM) is common in papillary thyroid carcinoma(PTC). LNM is related to local recurrence and adverse prognosis. The extent of prophylactic central lymph node dissection (pCLND) is not well defined. We aim to investigate the prevalence and risk factors for contralateral central lymph node metastasis (CCLNM) in unilateral clinical node-negative (cN0) PTC patients to determine the appropriate extent of pCLND. Methods: A systematic literature search was performed using PubMed and Embase databases until May 2018. Published studies that estimated the association between clinicopathologic factors and CCLNM were included. Results: A total of 6 studies involving 1399 patients were included. The prevalence of CCLNM was 10.9% in all patients. The pooled analysis revealed that male gender (pooled OR = 1.67, 95%CI = 1.11-2.53, p = 0.015), age < 45years (pooled OR = 1.97, 95%CI = 1.37-2.85, p < 0.001), lymphovasular invasion (pooled OR = 4.23, 95%CI = 2.25-7.98, p < 0.001), extrathyroid invasion (pooled OR = 1.75, 95%CI = 1.08-2.83, p = 0.023), and ipsilateral CLNM (pooled OR = 12.26, 95%CI = 7.27-20.67, p < 0.001) were significant risk factors for CCLNM. While tumor size > 1 cm (pooled OR = 3.39, 95%CI = 0.83-13.88, P = 0.090), capsular invasion (pooled OR = 1.28, 95%CI = 0.79-2.06, p = 0.313), extrathyroid extension (pooled OR = 1.49, 95%CI = 0.86-2.56, p = 0.152), and MACIS >= 6 (pooled OR = 1.08, 95%CI = 0.51-2.26, p = 0.844) were not significantly associated with CCLNM. Conclusions: Our meta-analysis identified that male gender, age < 45years, lymphovasular invasion, extrathyroid invasion and ipsilateral CLNM were significant risk factors for CCLNM. These findings may guide the extent of pCLND in unilateral cN0 PTC patients.
第一作者机构:[a]Department of General Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[a]Department of General Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China[c]School of Public Health, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China[*1]Department of General Surgery, Beijing Anzhen Hospital, Capital Medical University, Road #2, Chaoyang District, Beijing, China[*2]School of Public Health, Chinese Academy of Medical Science & Peking Union Medical College, DongDan SanTiao 9, DongCheng District, Beijing, China.
推荐引用方式(GB/T 7714):
Binbin Yan,Yingchen Hou,Dong Chen,et al.Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis[J].INTERNATIONAL JOURNAL OF SURGERY.2018,59:90-98.doi:10.1016/j.ijsu.2018.09.004.
APA:
Binbin Yan,Yingchen Hou,Dong Chen,Jianye He&Yu Jiang.(2018).Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.INTERNATIONAL JOURNAL OF SURGERY,59,
MLA:
Binbin Yan,et al."Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis".INTERNATIONAL JOURNAL OF SURGERY 59.(2018):90-98